Subtype
Female Reproductive System Neoplasm
CI-CAN-00000885Explore in graph →
Non-malignant1,630 active trials11 approved drugs139 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000885Explore in graph →
Clinical trials
7,171 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06677112 | MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer | recruiting | N/A | 625 | Rachel MillerOTHER | 1 | Nov 13, 2025 | clinicaltrials |
| NCT07084168 | Multimedia Aid for Genetic Testing in Gynecologic Oncology | recruiting | N/A | 30 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Nov 12, 2025 | clinicaltrials |
| NCT06677190 |
| Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin |
| recruiting |
| Phase 2 |
| 32 |
| Dana-Farber Cancer InstituteOTHER |
| 1 |
| Nov 5, 2025 |
| clinicaltrials |
| NCT07044505 | Molecular and Cellular Profiling of Uterine Lavage Collected During Gynecologic Surgery | recruiting | N/A | 50 | Stanford UniversityOTHER | 1 | Nov 5, 2025 | clinicaltrials |
| NCT05902988 | A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer | recruiting | Phase 1 / Phase 2 | 200 | Volastra Therapeutics, Inc.INDUSTRY | 1 | Nov 4, 2025 | clinicaltrials |
| NCT06481592 | A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer. | recruiting | Phase 2 | 60 | Iovance Biotherapeutics, Inc.INDUSTRY | 1 | Oct 30, 2025 | clinicaltrials |
| NCT03452774 | SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry | recruiting | — | 50,000 | Massive Bio, Inc.INDUSTRY | 2 | Oct 28, 2025 | clinicaltrials |
| NCT06617923 | Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer | recruiting | Phase 2 | 18 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Oct 27, 2025 | clinicaltrials |
| NCT05512208 | A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib(DURAFAK) | recruiting | Phase 2 | 55 | University of OklahomaOTHER | 1 | Oct 22, 2025 | clinicaltrials |
| NCT04586959 | Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer(MAN-U) | recruiting | N/A | 278 | Anthony Costales, MDOTHER | 1 | Oct 15, 2025 | clinicaltrials |
| NCT07213193 | No-Stoma Policy in Advanced Ovarian Cancer Surgery(No-Stoma) | recruiting | N/A | 395 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Oct 8, 2025 | clinicaltrials |
| NCT06560697 | Cervical Boost by Ablative Stereotactic Radiotherapy (SABR) vs Brachytherapy in Patients With Cervical Carcinoma(SABRVICAL) | recruiting | N/A | 84 | National Institute of CancerologíaOTHER_GOV | 1 | Oct 7, 2025 | clinicaltrials |
| NCT06817161 | Benefit of Transcutaneous Auricular Vagus Nerve Stimulation in Improving Quality of Life in First Line Treatment of Ovarian Cancer:(ESTANVO) | recruiting | Phase 3 | 116 | Centre Francois BaclesseOTHER | 1 | Oct 7, 2025 | clinicaltrials |
| NCT04644289 | WoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOC(WoO) | recruiting | Phase 2 | 60 | AGO Research GmbHINDUSTRY | 1 | Oct 3, 2025 | clinicaltrials |
| NCT07166042 | Guided Meditation During Radiation Therapy for Breast and Gynecological Malignancies(Med-RT BG) | recruiting | Phase 3 | 34 | University of UtahOTHER | 1 | Oct 3, 2025 | clinicaltrials |
| NCT00722228 | Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors | recruiting | Phase 1 / Phase 2 | 50 | Hadassah Medical OrganizationOTHER | 1 | Oct 2, 2025 | clinicaltrials |
| NCT04098744 | Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)(ART-CIN_IIB) | recruiting | Phase 2 | 78 | Frantz Viral Therapeutics, LLCINDUSTRY | 1 | Oct 2, 2025 | clinicaltrials |
| NCT07202728 | A Multi-center Cohort Study of Hydatidiform Mole in China (CN-HM-01)(CN-HM-01) | recruiting | — | 1,489 | Obstetrics & Gynecology Hospital of Fudan UniversityOTHER | 1 | Oct 2, 2025 | clinicaltrials |
| NCT04512144 | Mindfulness in Endometrial and Cervical Cancer(MECCA) | recruiting | N/A | 120 | St. Louis UniversityOTHER | 1 | Sep 30, 2025 | clinicaltrials |
| NCT04111978 | MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)(MATAO) | recruiting | Phase 3 | 540 | Swiss GO Trial GroupNETWORK | 3 | Sep 29, 2025 | clinicaltrials |
| NCT05990803 | A Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Recurrent or Metastatic Cervical Cancer and Other Gynecological Malignancies | recruiting | Phase 2 | 130 | Sichuan Baili Pharmaceutical Co., Ltd.INDUSTRY | 1 | Sep 26, 2025 | clinicaltrials |
| NCT06619769 | eSense-Cancer: Adapting an Online Intervention for Sexual Health Concerns to Gynecologic Cancer(eSense-Cancer) | recruiting | N/A | 60 | University of British ColumbiaOTHER | 1 | Sep 25, 2025 | clinicaltrials |
| NCT05197881 | Daily Adaptive Radiation Therapy an Individualized Approach for Carcinoma of the Cervix(ARTIA-Cervix) | recruiting | N/A | 125 | Varian, a Siemens Healthineers CompanyINDUSTRY | 1 | Sep 23, 2025 | clinicaltrials |
| NCT05606133 | Circulating Human Papilloma Virus (HPV) DNA for the Screening and Surveillance of Gynecologic Cancers | recruiting | N/A | 100 | Northwell HealthOTHER | 1 | Sep 23, 2025 | clinicaltrials |
| NCT07027046 | Application of da Vinci SP for Endometrial Cancer Surgical Staging | recruiting | — | 564 | National Cancer Institute, NaplesOTHER | 1 | Sep 19, 2025 | clinicaltrials |
| NCT06518746 | Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation | recruiting | N/A | 50 | University of Colorado, DenverOTHER | 1 | Sep 18, 2025 | clinicaltrials |
| NCT06731998 | Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery(LapTAP) | recruiting | N/A | 48 | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)OTHER | 1 | Sep 18, 2025 | clinicaltrials |
| NCT05329532 | Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer(ModiFY) | recruiting | Phase 1 / Phase 2 | 168 | Scancell LtdINDUSTRY | 1 | Sep 17, 2025 | clinicaltrials |
| NCT06152731 | HRD Tests for Ovarian cancER(HERO) | recruiting | Phase 2 | 88 | Centre Francois BaclesseOTHER | 1 | Sep 17, 2025 | clinicaltrials |
| NCT04794322 | Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer | recruiting | — | 250 | Massachusetts General HospitalOTHER | 1 | Sep 16, 2025 | clinicaltrials |
| NCT03958240 | Deciphering Mechanisms Underlying Cancer Immunogenicity(DECIDE) | recruiting | N/A | 1,100 | Institut Claudius RegaudOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT07078682 | An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms | recruiting | N/A | 42 | Zenchi, Inc.INDUSTRY | 1 | Sep 12, 2025 | clinicaltrials |
| NCT07171528 | Secondary Cytoreductive Surgery After Chemotherapy for Recurrent Epithelial Ovarian Cancer(KOV-02S) | recruiting | Phase 2 | 80 | National Cancer Center, KoreaOTHER_GOV | 1 | Sep 12, 2025 | clinicaltrials |
| NCT05998135 | Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer | recruiting | Phase 2 | 28 | Emory UniversityOTHER | 1 | Sep 11, 2025 | clinicaltrials |
| NCT06709534 | An Individualized Online Home-Based Exercise Program for Improving Symptoms in Gynecologic Cancer Survivors | recruiting | N/A | 40 | Emory UniversityOTHER | 1 | Sep 11, 2025 | clinicaltrials |
| NCT07055399 | Neoadjuvant Iparomlimab and Tuvonralimab Plus Chemotherapy-eclipse for Locally Advanced Cervical Cancer (NICE-CC)(NICE-CC) | recruiting | Phase 2 | 43 | Fujian Cancer HospitalOTHER_GOV | 1 | Sep 11, 2025 | clinicaltrials |
| NCT05009082 | Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer | recruiting | Phase 3 | 970 | AGO Study GroupOTHER | 1 | Sep 10, 2025 | clinicaltrials |
| NCT05107674 | A Study of NX-1607 in Adults With Advanced Malignancies | recruiting | Phase 1 | 345 | Nurix Therapeutics, Inc.INDUSTRY | 2 | Sep 9, 2025 | clinicaltrials |
| NCT07156253 | Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tumors | recruiting | Phase 1 | 110 | Hangzhou SynRx Therapeutics Biomedical Technology Co., LtdINDUSTRY | 1 | Sep 5, 2025 | clinicaltrials |
| NCT06169449 | Weight Management in Overweight Endometrial Cancer Patients Undergoing Fertility-sparing Treatment | recruiting | N/A | 240 | Peking University People's HospitalOTHER | 1 | Sep 3, 2025 | clinicaltrials |
| NCT04555226 | The Efficacy of Lymph Node Dissection for Stage IIICr of Cervical Cancer(CQGOG0103) | recruiting | N/A | 452 | Chongqing University Cancer HospitalOTHER | 1 | Sep 2, 2025 | clinicaltrials |
| NCT07148154 | Development of a Non-invasive IVD for Endometrial Cancer Screening on High-risk Populations | recruiting | — | 3,000 | MiMARK Diagnostics, S.L.INDUSTRY | 1 | Aug 29, 2025 | clinicaltrials |
| NCT03878849 | Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer | recruiting | Phase 2 | 40 | Allarity TherapeuticsINDUSTRY | 1 | Aug 28, 2025 | clinicaltrials |
| NCT07146659 | Comparison of Operative Hysteroscopy Performed in the Operating Room Versus Outpatient Settings | recruiting | — | 400 | Centre Hospitalier Intercommunal CreteilOTHER | 1 | Aug 28, 2025 | clinicaltrials |
| NCT05113368 | Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer | recruiting | Phase 2 | 31 | Sarah K. Lynam MDOTHER | 1 | Aug 21, 2025 | clinicaltrials |
| NCT06508307 | A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors | recruiting | Phase 1 | 21 | GONGCHU Biotechnology Co., LtdOTHER | 1 | Aug 21, 2025 | clinicaltrials |
| NCT06514235 | Image-guided Brachytherapy for Vaginal Cancer (EMBRAVE)(EMBRAVE) | recruiting | — | 300 | Erasmus Medical CenterOTHER | 1 | Aug 19, 2025 | clinicaltrials |
| NCT07130240 | Ivonescimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy Followed by Type A Hysterectomy in Stage IB2 and IIA1 Cervical Cancer | recruiting | Phase 2 | 20 | Obstetrics & Gynecology Hospital of Fudan UniversityOTHER | 1 | Aug 19, 2025 | clinicaltrials |
| NCT06953076 | Ultrasound Transformation of Myomas During Relugolix-Estradiol-Norethisterone Treatment: The MySaturn Study(MySaturn) | recruiting | — | 111 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Aug 17, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Nov 13, 2025source: clinicaltrials